Rochester Medical Announces New Opportunity in the United Kingdom
September 21 2009 - 2:37PM
PR Newswire (US)
FemSoft(R) Insert for female stress urinary incontinence has been
approved for reimbursement by the United Kingdom's National Health
Service. STEWARTVILLE, Minn., Sept. 21 /PRNewswire-FirstCall/ --
Rochester Medical Corporation (NASDAQ:ROCM) today announced that
the Company's FemSoft Insert has been approved for inclusion in
Part IX of the UK Drug Tariff as a prescription product which is
reimbursable. There are no other products listed in the Drug Tariff
specifically for managing female stress urinary incontinence, and
the Company believes that for many women this will be a very
welcome addition that offers a discreet, non-surgical, odor-free,
secure, and safe alternative to absorbents. FemSoft Inserts are
particularly effective in situations where leakage occurs during
certain physical activities such as exercise, coughing, laughing,
or sneezing. Hugh McLeod, General Manager of the U.K. business
commented that this represents a significant opportunity for
Rochester Medical and will enhance the Company's position as the
leading worldwide innovator and marketer of silicone continence
care devices. He noted that the FemSoft Insert product line fits
perfectly alongside Rochester Medical's current portfolio of
catheters for intermittent self-catheterization and will be
marketed through the same customer base of Urology Nurse
Specialists and Continence Nurse Specialists. Commenting on the
news, Anthony J. Conway Rochester Medical CEO and President said,
"This is excellent news for women in the United Kingdom and also
great news for Rochester Medical. We believe the FemSoft Insert
provides an elegant non-surgical, comfortable, and dry alternative
to absorbents. Earlier this year we announced that U.S. Medicare
has given preliminary reimbursement approval to the FemSoft Insert,
and we expect final confirmation in the near future. In both the
U.K. and U.S. we expect implementation of the reimbursement to
begin in January 2010, and we are making sales and marketing
preparations accordingly." About Rochester Medical Rochester
Medical is the world's leading manufacturer of all-silicone
catheters for urological and continence care applications. Our
advanced line of latex-free products features male external
catheters, intermittent catheters, Foley catheters and urethral
inserts as well as latex-free accessories. More information about
Rochester Medical is available on its website at
http://www.rocm.com/. Forward-Looking Statement This press release
contains "forward-looking statements" that are based on currently
available information, operating plans and management's
expectations about future events and trends. They inherently
involve risks and uncertainties that could cause actual results to
differ materially from those predicted in such forward-looking
statements, including the uncertainty of estimated revenues and
profits, the uncertainty of current domestic and international
economic conditions that could adversely affect the level of demand
for the Company's products and increased volatility in foreign
exchange rates, the uncertainty of market acceptance of new product
introductions, the uncertainty of gaining new strategic
relationships or locating and capitalizing on strategic
opportunities, the uncertainty of timing of private label sales
revenues (particularly international customers), FDA and other
regulatory review and response times, and other risk factors listed
from time to time in the Company's SEC reports and filings,
including, without limitation, the section entitled "Risk Factors"
in the Company's Annual Report on Form 10-K for the year ended
September 30, 2008 and subsequent reports on Forms 10-Q and 8-K.
Readers are cautioned not to place undue reliance on any such
forward-looking statements, which speak only as of the date they
are made. The Company undertakes no obligation to update any
forward-looking statements, whether as a result of new information,
future events or otherwise. Contact: Anthony J. Conway President
and Chief Executive Officer Rochester Medical Corporation Phone:
(507) 533-9600 DATASOURCE: Rochester Medical Corporation CONTACT:
Anthony J. Conway, President and Chief Executive Officer of
Rochester Medical Corporation, +1-507-533-9600 Web Site:
http://www.rocm.com/
Copyright